Cost & Coverage
Who's Using GLP-1s Now? The 2026 Numbers, Explained
GLP-1 use hit a new high in 2026: about 11% of US adults now take one. See who is using them, the brand vs compounded split, and what it means.
Category
Affordability
13 stories tagged affordability. Browse all of Cost & Coverage
Cost & Coverage
The GLP-1 Price War: What Cheaper Options Mean for You
Brand GLP-1 cash prices are falling fast. See what Ozempic, Wegovy, and Zepbound cost now, why, and whether your own bill will drop.
Cost & Coverage
How LillyDirect Works, and Where the "Deals" Can Cost You
LillyDirect offers self-pay prices and easy access, but a Senate report raises questions about steering + cost. See how it works and what to watch.
Cost & Coverage
What Medicare's $50 GLP-1 Plan Actually Means for You (Updated Sept 2026)
The $50 Medicare GLP-1 copay applies at every income. See who qualifies, which plans work, and the one fill that ends eligibility.
Cost & Coverage
Why GLP-1 Costs Tend to Go Up After You Start Taking It
Wegovy and Zepbound coverage is dropping for millions. Learn why GLP-1 prices often jump after you start, and what to do when your costs change.
Medications
The Novo Nordisk and Hims Deal: What It Means for GLP-1 Pricing and Access
Novo Nordisk and Hims struck a deal on Ozempic and Wegovy pricing. See what it means for GLP-1 costs, compounded access, and your options.
Medications
If Ozempic Costs $3 to Make, Why Does It Cost $900?
GLP-1 shots cost under $5 to make but sell for $900+. See what drives the price, whether it's justified, and how pricing is changing in 2026.
Cost & Coverage
Will India’s GLP-1 Patent Expiry Impact the GLP-1 Market in the US?
India’s GLP-1 patent expiry may lower prices there first. Learn what it could mean for US access and affordability.
Cost & Coverage
What New GLP-1 and Obesity Medication Trials Are Happening Now (and Why They Matter)
Major GLP-1 and obesity drug trials are finishing in 2027. Here’s what they’re studying and what it could mean for access and affordability.
Cost & Coverage
Indiana, Florida, and Federal GLP-1 Compounding Law Update – February 2026
Latest updates on Indiana, Florida, and federal GLP-1 compounding laws and what the changes could mean for patient access in 2026.
Medications
GLP-1 Costs Are Pushing People Off Their Meds. Here’s What You Can Actually Do About It.
High cost and poor coverage make people stop GLP-1s early, reducing benefits and adherence.
Medications
Tirzepatide Changes - We’re actively updating for compounded compliance changes
We're working hard to keep things updated but give us some grace as providers potentially change their offerings around tirzepatide.
Medications
Hims & Hers Super Bowl Ad: Not Actually Changing the System
I want to challenge Hims… Why do you advertise and encourage patients who are new to this medication to buy 12 months upfront?